In contrast, p-eIF2α was predicted to negatively regulate tumor suppressors like the homeobox protein HOXA10, estrogen-related receptor alpha (ESRRA), polycomb group protein ASXL1, and mitofusin 2 (MFN2) function (Fig. 2g)43–46. Here, EIF2A is linked to neoplasm.